CA9 and cervical cancer: However, Liao et al. demonstrated that immunohistochemical CAIX expression is an independent prognostic factor for both progression-free survival and overall survival in patients with high-risk, early-stage cervical cancer who received adjuvant pelvic radiotherapy with or without radiosensitizing chemotherapy [38].